Third Quarter Earnings Release and Upcoming Conference - Research Reports on Vale, Pioneer, Tesoro, Praxair and Ensco

NEW YORK, November 4, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Vale S.A. (NYSE: VALE), Pioneer Natural Resources Co. (NYSE: PXD), Tesoro Corporation (NYSE: TSO), Praxair Inc. (NYSE: PX) and Ensco plc (NYSE: ESV). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7687-100free.

--
Vale S.A. Research Reports
On October 30, 2014, Vale S.A. (Vale) reported its Q3 2014 results. The gross operating revenues were reported at $9.2 billion, down 26.0% YoY due to the lower commodity prices, which were offset by higher sales volumes. The net loss was $1.4 billion as compared to net earnings of $3.5 billion in Q3 2013 and diluted loss per share was reported at $0.28, against a Q3 2014 diluted EPS of $0.68. The Company stated that it has reached record level of iron-ore production (excluding Samarco's attributable production of 3.8 Mt) of 85.7 million tonnes (Mt) in Q3 2014, supported by the ramp-ups of Plant 2 in Carajás and of Conceição Itabiritos in the Southeastern System. In terms of revenue by business, the contribution of base metals -copper, nickel etc to the operating revenues increased from 14.9% in Q3 2013 to 23.0% in Q3 2014. Meanwhile, revenue contribution from Asia declined from 58.4% in Q3 2013 to 49.2% sales, while the same from Americas increased from 19.8% in Q3 2013 to 28.7% in Q3 2014. The full research reports on Vale are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/VALE/report.pdf

--
Pioneer Natural Resources Co. Research Reports
As per the Event section of Pioneer Natural Resources Co. (Pioneer), the Company is scheduled to participate at Capital One Securities Energy Conference on December 10, 2014, at 8:20 a.m. CT at Omni Royal Orleans Hotel in New Orleans, Louisiana, US. The full research reports on Pioneer are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/PXD/report.pdf

--
Tesoro Corporation Research Reports
On October 30, 2014, Tesoro Corporation (Tesoro) reported financials for its Q3 2014 performance. The revenues for the quarter came in at $11.2 billion, down 0.8% YoY and total diluted EPS was $3.05, against $0.72 in Q3 2013. The Company recorded segment operating income of $777 million, compared to $197 million in Q3 2013, which comprises of $578 million from the refining division, $61 million from Tesoro Logistics LP (TLLP), and $138 million from Retail segment. The Company also announced a regular quarterly cash dividend of $0.30 per share, payable on December 15, 2014 to all holders of record as of November 28, 2014. The full research reports on Tesoro are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/TSO/report.pdf

--
Praxair Inc. Research Reports
On October 29, 2014, Praxair Inc. (Praxair) reported Q3 2014 financial results. The Company reported adjusted EPS of $1.62 per share, which was lower than Zacks consensus estimate of $1.63 per share. The sales for the quarter came in at $3.1 billion, up 4.3% YoY. The increase can be attributed to 5% increase in organic sales driven by new project start-ups, in North America, South America and Asia, and higher price across all operating segments. In terms of segment, North America reported sales of $1.6 billion, up 3.2% YoY and organic sales growth was 2%, led by higher pricing and increased sales to the manufacturing, metals, food and beverage and healthcare end-markets. On the other hand Europe sales declined 0.3% YoY to $385 million. South America segment sales increased 5.9% YoY and sales in Asia surged 10.6% YoY. The Company for Q4 2014 expects diluted EPS within the range of $1.53 to $1.60 and for year 2014 it forecasts sales to vary between $12.3 billion and $12.4 billion with diluted EPS to be in the range of $6.23 and $6.30. The full research reports on Praxair are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/PX/report.pdf

--
Ensco plc Research Reports
On October 29, 2014, Ensco plc (Ensco) reported its Q3 2014 results. The revenue for the quarter was $1.3 billion, up 8.5% YoY. On segmental basis, its Floaters revenue increased 6.9% YoY to $745.3 million, due to ENSCO DS-7 commencing its initial contract. On the other hand, Jackup revenues increased 11.6% YoY to $499 million due to the addition of ENSCO 120 and ENSCO 121 to the active fleet as these jackups commenced their initial contracts. Diluted EPS was $1.83 in Q3 2014, up 13.0% YoY. Ensco's CEO and President, Carl Trowell said, "We achieved record revenues due to strong operational performance and new rigs joining our fleet. Future revenues will benefit from more than $1 billion of backlog that we added recently when we signed several multi-year contracts with repeat customers." The full research reports on Ensco are available to download free of charge at:

http://www.analystsreview.com/Nov-04-2014/ESV/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review